HPV jab using same tech as AstraZeneca Covid vaccine could combat cervical cancer in adults

HPV jab which uses same technology as AstraZeneca Covid vaccine could combat cervical cancer in adults

• Trial is under way at several NHS hospitals giving more than 50 women who test positive for pre-cancerous tissue on their cervix a specially designed HPV jab
• Researchers will examine whether pre-cancerous tissue is still on the cervix, along with any traces of HPV (human papillomavirus), an infection almost always present when women develop this cancer
• The trial, called Apollo, involves a vaccine called VTP-200, which targets HPV
• It is different from HPV jab given to teenagers as it uses an inactivated chimpanzee adenovirus – same technology as in AstraZeneca Covid jab

By Ethan Ennals For The Mail On Sunday

Published: 18:55 EDT, 30 April 2022 | Updated: 18:59 EDT, 30…